Ana SayfaNHIQ • OTCMKTS
add
NantHealth Inc
Önceki kapanış
$0,00010
Günlük aralık
$0,00010 - $0,00010
Piyasa değeri
2,75 B USD
Ort. Hacim
187,00
F/K oranı
-
Temettü getirisi
-
Birincil borsa
OTCMKTS
Piyasa haberleri
Finansal Bilgiler
Gelir Tablosu
Gelir
Net gelir
(USD) | Eyl 2023info | Yıldan yıla değişim |
---|---|---|
Gelir | 12,47 Mn | — |
İşletme masrafı | 12,17 Mn | — |
Net gelir | -14,99 Mn | — |
Net kâr marjı | -120,20 | — |
Hisse senedi başına kazanç | — | — |
FAVÖK | -175,00 B | — |
Fiilî vergi oranı | -%0,36 | — |
Bilanço
Toplam varlık
Toplam sorumluluk
(USD) | Eyl 2023info | Yıldan yıla değişim |
---|---|---|
Nakit ve kısa vadeli yatırım | 5,82 Mn | — |
Toplam varlık | 146,48 Mn | — |
Toplam sorumluluk | 396,66 Mn | — |
Toplam net varlık | -250,18 Mn | — |
Tedavüldeki hisse senetleri | 27,47 Mn | — |
Fiyat/defter değeri | -0,00 | — |
Aktif kârlılık oranı | -%8,24 | — |
Sermaye kârlılığı | -%41,68 | — |
Nakit Akışı
Net nakit değişimi
(USD) | Eyl 2023info | Yıldan yıla değişim |
---|---|---|
Net gelir | -14,99 Mn | — |
İşletme faal. nakit akışı | -7,65 Mn | — |
Yatırımdan nakit akışı | 11,00 B | — |
Finansmandan nakit akışı | 7,50 Mn | — |
Net nakit değişimi | -298,00 B | — |
Serbest nakit akışı | -3,94 Mn | — |
Hakkında
NantHealth, Inc. is a provider of software solutions for the healthcare industry, including NaviNet for insurance companies and decision support systems targeted at healthcare. The publicly traded company is headquartered in Winterville, North Carolina.
The company was founded by Patrick Soon-Shiong. His investment portfolio NantWorks controlled 62% of the voting shares of NantHealth at the end of 2021. Other notable early investors included Allscripts, BlackBerry, Kuwait Investment Authority, Celgene, and Verizon.
In September 2014, NantHealth was featured as the cover story in Forbes Magazine, which estimated NantHealth's market capitalization at $1.6 billion. In December 2014, NantHealth was featured on 60 Minutes by Sanjay Gupta. In August 2017, NantHealth signed a distribution agreement for GPS Cancer with Asia Genomics.
In January 2019, NantHealth received a delisting warning from Nasdaq "because the Company’s common stock failed to maintain a minimum closing bid price of $1.00 for 30 consecutive business days." At the time, the market value of the company was approximately $57m. The company made a 1-for-15 reverse stock split in December, 2022. Wikipedia
Kuruluş
7 Tem 2010
İnternet sitesi
Çalışanlar
373